Literature DB >> 29282702

Treatment of dizziness: an interdisciplinary update.

Rainer Spiegel1, Heiko Rust2, Thomas Baumann3, Hergen Friedrich4, Raoul Sutter5, Martina Göldlin6, Christiane Rosin7, René Müri6, Georgios Mantokoudis4, Roland Bingisser7, Michael Strupp8, Roger Kalla6.   

Abstract

This review provides an update on interdisciplinary treatment for dizziness. Dizziness can have various causes and the treatment offered should depend on the cause. After reading this article, the clinician will have an overview of current treatment recommendations. Recommendations are made for the most prevalent causes of dizziness including acute and chronic vestibular syndromes, vestibular neuritis, benign paroxysmal positional vertigo, endolymphatic hydrops and Menière’s disease, vestibular paroxysmia and vestibular migraine, cardiac causes, transient ischaemic attacks and strokes, episodic ataxia type 2, persistent postural-perceptual dizziness, bilateral vestibulopathy, degenerative, autoimmune and neoplastic diseases, upbeat- and downbeat nystagmus. Recommendations include clinical approaches (repositioning manoeuvres), medication (adding, removing or changing current medication depending on aetiology), vestibular physiotherapy, ergotherapy and rehabilitation, treatment of chest pain or stroke units and surgical interventions. If symptoms are acute and severe, medication with antivertigo agents is recommended as a first step, for a maximum period of 3 days. Following initial symptom control, treatment is tailored depending on aetiology. To assist the clinician in obtaining a useful overview, the level of evidence and number needed to treat are reported whenever possible based on study characteristics. In addition, warnings about possible arrhythmias due to medication are issued, and precautions to enable these to be avoided are discussed.

Entities:  

Mesh:

Year:  2017        PMID: 29282702     DOI: 10.4414/smw.2017.14566

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  7 in total

1.  Development of a complex intervention to improve mobility and participation of older people with vertigo, dizziness and balance disorders in primary care: a mixed methods study.

Authors:  Verena Regauer; Eva Seckler; Eva Grill; Richard Ippisch; Klaus Jahn; Petra Bauer; Martin Müller
Journal:  BMC Fam Pract       Date:  2021-05-12       Impact factor: 2.497

2.  Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern China.

Authors:  Peng Liu; Shaolin Ma; Guixiang Du; Shengde Sun; Xin Zhang; Peng Tang; Chen Hou; Yue Liu; Jiaxing Zhao; Xiaohui Zhang; Li Chen; Chaochao Gu; Lina Zhang; Li Chong; Xu Yang; Rui Li
Journal:  J Gen Intern Med       Date:  2021-01-26       Impact factor: 6.473

Review 3.  Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review.

Authors:  Ahmad H Alghadir; Shahnawaz Anwer
Journal:  Front Neurol       Date:  2018-06-12       Impact factor: 4.003

4.  Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial.

Authors:  Ali Arhami Dolatabadi; Seyedeh Roghieh Larimi; Arash Safaie
Journal:  Arch Acad Emerg Med       Date:  2019-01-23

5.  Physical therapy interventions for older people with vertigo, dizziness and balance disorders addressing mobility and participation: a systematic review.

Authors:  Verena Regauer; Eva Seckler; Martin Müller; Petra Bauer
Journal:  BMC Geriatr       Date:  2020-11-23       Impact factor: 3.921

6.  Cervicogenic dizziness alleviation after coblation discoplasty: a retrospective study.

Authors:  Liang-Liang He; Ru-Jing Lai; Jacqueline Leff; Rong Yuan; Jian-Ning Yue; Jia-Xiang Ni; Li-Qiang Yang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 7.  The Treatment of Vestibular Migraine: A Narrative Review.

Authors:  Youjin Shen; Xiaokun Qi; Tingyu Wan
Journal:  Ann Indian Acad Neurol       Date:  2020-02-11       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.